Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

PLGA-loaded nanomedicines in melanoma treatment: Future prospect for efficient drug delivery.

Das S, Khuda-Bukhsh AR.

Indian J Med Res. 2016 Aug;144(2):181-193. doi: 10.4103/0971-5916.195024. Review.

2.

An approach to prioritization of medical devices in low-income countries: an example based on the Republic of South Sudan.

Lilford RJ, Burn SL, Diaconu KD, Lilford P, Chilton PJ, Bion V, Cummins C, Manaseki-Holland S.

Cost Eff Resour Alloc. 2015 Jan 10;13(1):2. doi: 10.1186/s12962-014-0027-3. eCollection 2015.

3.

Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity.

Depelsenaire ACI, Meliga SC, McNeilly CL, Pearson FE, Coffey JW, Haigh OL, Flaim CJ, Frazer IH, Kendall MAF.

J Invest Dermatol. 2014 Sep;134(9):2361-2370. doi: 10.1038/jid.2014.174. Epub 2014 Apr 8.

4.

Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.

Gregory JA, Topol AB, Doerner DZ, Mayfield S.

Appl Environ Microbiol. 2013 Jul;79(13):3917-25. doi: 10.1128/AEM.00714-13. Epub 2013 Apr 19.

5.

Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination.

Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ.

Adv Funct Mater. 2013 Jan 14;23(2):161-172.

6.

Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.

DeMuth PC, Moon JJ, Suh H, Hammond PT, Irvine DJ.

ACS Nano. 2012 Sep 25;6(9):8041-51. Epub 2012 Aug 30.

7.

The HIV Epidemic: High-Income Countries.

Vermund SH, Leigh-Brown AJ.

Cold Spring Harb Perspect Med. 2012 May;2(5):a007195. doi: 10.1101/cshperspect.a007195. Review.

8.

Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies.

Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS.

Vaccine. 2012 Jun 6;30(26):3965-74. doi: 10.1016/j.vaccine.2012.03.026. Epub 2012 Mar 23.

9.

DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Gorres JP, Lager KM, Kong WP, Royals M, Todd JP, Vincent AL, Wei CJ, Loving CL, Zanella EL, Janke B, Kehrli ME Jr, Nabel GJ, Rao SS.

Clin Vaccine Immunol. 2011 Nov;18(11):1987-95. doi: 10.1128/CVI.05171-11. Epub 2011 Sep 14.

10.

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.

Higginson D, Theodoratou E, Nair H, Huda T, Zgaga L, Jadhav SS, Omer SB, Rudan I, Campbell H.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S31. doi: 10.1186/1471-2458-11-S3-S31. Review.

11.

Intradermal delivery of vaccines: potential benefits and current challenges.

Hickling JK, Jones KR, Friede M, Zehrung D, Chen D, Kristensen D.

Bull World Health Organ. 2011 Mar 1;89(3):221-6. doi: 10.2471/BLT.10.079426. Epub 2011 Jan 5.

12.

Plant-made vaccines in support of the Millennium Development Goals.

Penney CA, Thomas DR, Deen SS, Walmsley AM.

Plant Cell Rep. 2011 May;30(5):789-98. doi: 10.1007/s00299-010-0995-5. Epub 2011 Jan 18. Review.

13.

Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA.

DeMuth PC, Su X, Samuel RE, Hammond PT, Irvine DJ.

Adv Mater. 2010 Nov 16;22(43):4851-6. doi: 10.1002/adma.201001525. No abstract available.

14.

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.

Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, Opio A, Downing R, Biryahwaho B, Lewis RF.

Afr Health Sci. 2009 Jun;9(2):98-108.

15.

Supplemental Content

Support Center